- Home
- CRGY vs APGE Comparison
CRGY vs APGE Comparison
Compare CRGY & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGY
- APGE
- Stock Information
- Founded
- CRGY 1986
- APGE 2022
- Country
- CRGY United States
- APGE United States
- Employees
- CRGY N/A
- APGE N/A
- Industry
- CRGY Oil & Gas Production
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRGY Energy
- APGE Health Care
- Exchange
- CRGY Nasdaq
- APGE Nasdaq
- Market Cap
- CRGY 2.1B
- APGE 1.8B
- IPO Year
- CRGY N/A
- APGE 2023
- Fundamental
- Price
- CRGY $11.13
- APGE $39.72
- Analyst Decision
- CRGY Buy
- APGE Strong Buy
- Analyst Count
- CRGY 11
- APGE 4
- Target Price
- CRGY $17.56
- APGE $91.33
- AVG Volume (30 Days)
- CRGY 4.6M
- APGE 789.4K
- Earning Date
- CRGY 05-05-2025
- APGE 03-03-2025
- Dividend Yield
- CRGY 4.31%
- APGE N/A
- EPS Growth
- CRGY N/A
- APGE N/A
- EPS
- CRGY N/A
- APGE N/A
- Revenue
- CRGY $2,930,919,000.00
- APGE N/A
- Revenue This Year
- CRGY $33.58
- APGE N/A
- Revenue Next Year
- CRGY $0.92
- APGE $795.25
- P/E Ratio
- CRGY N/A
- APGE N/A
- Revenue Growth
- CRGY 23.01
- APGE N/A
- 52 Week Low
- CRGY $9.88
- APGE $29.10
- 52 Week High
- CRGY $16.94
- APGE $68.21
- Technical
- Relative Strength Index (RSI)
- CRGY 36.32
- APGE 55.27
- Support Level
- CRGY $11.38
- APGE $38.18
- Resistance Level
- CRGY $11.77
- APGE $41.07
- Average True Range (ATR)
- CRGY 0.38
- APGE 2.31
- MACD
- CRGY 0.16
- APGE 0.22
- Stochastic Oscillator
- CRGY 54.04
- APGE 63.77
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.